There were 2,133 press releases posted in the last 24 hours and 403,415 in the last 365 days.

UPDATE - Igneous Selected by Syros Pharmaceuticals to Modernize HPC Backup Environment

SEATTLE, Sept. 27, 2019 (GLOBE NEWSWIRE) -- Igneous, Inc., the Seattle-based startup delivering the only Unstructured Data Management (UDM) solution, has been selected by Syros Pharmaceuticals to modernize its data protection infrastructure. 

Founded in 2012, Syros is a leader in the development of medicines that control the expression of genes. Computational biology is a core component of its research and development efforts, and as its data-related needs grew, Syros sought a data-solutions provider to help ensure that its data was protected with a scalable backup, archive, and restore system.

By integrating Igneous DataProtect backup into its high-performance computing (HPC) architecture, Syros can back up and recover millions or even billions of files without impacting its NAS performance and without the operating and capital expense associated with traditional systems.

For more information, visit igneous.io, or follow us on Twitter @IgneousIO and on LinkedIn at www.linkedin.com/company/igneous.

About Igneous
Igneous delivers the only heterogeneous Unstructured Data Management (UDM) solution for data-centric organizations. The Igneous solution provides organizations the ability to see, protect, and leverage their unstructured datasets wherever they live through Igneous DataProtect, DataDiscover, and DataFlow services. Have the right data in the right place, at the right time.

Press Contact:                  
Holly Hagerman
Connect Marketing                                    
801.373.7888
hollyh@connectmarketing.com

Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.